Posts

Showing posts with the label Atherectomy Devices Market Revenue

Atherectomy Devices Market Is Expected To Reach USD 894.69 Million By 2025 : Grand View Research Inc.

San Francisco, 27 August 2019:   The Report   Atherectomy Devices Market   Analysis By Type (Directional Atherectomy, Rotational Atherectomy, Orbital Atherectomy, Laser Atherectomy), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2018 – 2025 The global atherectomy devices market size was valued at USD 894.69 million by 2025 and is projected to grow with CAGR of 6.97% over the forecast period. The rising prevalence of target diseases is the key driver of the market. More than 250 million people worldwide suffer from peripheral artery disease (PAD), which also includes low-income countries to some extent. The prevalence of PAD increased by 24% between 2000 to 2010 and continues to grow at an exponential rate. Both high- and low-income countries have this prevalence. Low-income countries witnessed a growth of 29%, while high-income countries witnessed a growth of 13% in the last decade. New technologies and product approvals are expected t

Atherectomy Devices Market Size Projected To Reach USD 894.69 Million By 2025 : Grand View Research Inc.

San Francisco, 24 May 2019:  The Report  Atherectomy Devices Market  Analysis By Type (Directional Atherectomy, Rotational Atherectomy, Orbital Atherectomy, Laser Atherectomy), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2018 – 2025 The global Atherectomy Devices Market is expected to reach USD 894.69 million by 2025, based on a new report by Grand View Research, Inc. The demand for atherectomy devices market is anticipated to boost over the forecast period due to rapidly rising incidence of target diseases such as peripheral artery disease. New technologies and product approvals are expected to boost the market for orbital and laser atherectomy devices over the forecast period. For instance, in July 2016, Cardiovascular Systems Inc. submitted an application for approval to Pharmaceuticals and Medical Devices Agency (PMDA), Japan’s regulatory agency for pharmaceuticals and medical devices. The company intends to launch Diamondback 360